2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk

Absci TodayABSIAbsci$3.62 -0.07 (-1.77%) 52-Week Range$2.01▼$6.33Price Target$7.98Add to WatchlistThe biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains. Firms in this space often either make it big—spiking upon news of a promising trial or a drug that will make it to market—or crash and burn. As a penny stock with a market cap of just $600 million, Absci Corp. NASDAQ: ABSI falls squarely in the high-risk, high-reward category. The compan ...